Intellectual Property

Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.



Sign up for a 7-day FREE trial today!



Latest News in Intellectual Property

  • June 17, 2026

    Eve Legal Accused By AI.Law Of Infringing AI Drafting Tech

    Eve Legal ripped off legal tech company AI.Law's patent that allows lawyers and other legal professionals to use artificial intelligence to generate legal documents, AI.Law alleged in a patent infringement lawsuit filed Wednesday in California federal court.

  • June 17, 2026

    Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win

    Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision runs afoul of the justices' Amgen holding and "opens a truck-sized hole in enablement and written description law."

  • June 17, 2026

    Acer Can't Nix Texas Jury's $10M Verdict Over Monitor Patents

    A Texas federal judge rejected Acer's effort to wipe out a jury's $10.3 million infringement award to rival SVV Technology Innovations over optical-film patents for monitors, finding the jury's verdict was supported by the evidence and the company's criticism of an SVV expert's methodology is too late.

  • June 17, 2026

    Hikma Ruling Raises Patent Pleading Bar Beyond Drug Cases

    The U.S. Supreme Court's decision this month that shut down a patent suit against Hikma Pharmaceuticals USA over a drug using a so-called skinny label could also make it more challenging to plead induced infringement in cases involving other technologies, attorneys say.

  • June 17, 2026

    Sen. Committee Clears Drug Disclosure, Biosimilar Bills

    The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need for more interchangeable biosimilars.

See more Intellectual Property news

Intellectual Property

Areas of Coverage

  • LITIGATION
  • Infringement suits over patents, copyrights, and trademarks
  • Patent Trial and Appeal Board disputes
  • Abbreviated New Drug Application (ANDA) litigation
  • Section 301 cases
  • Trade secrets disputes
  • Licensing and royalty fights
  • Right-of-publicity suits
  • Antitrust disputes involving IP issues
  • AGENCIES
  • U.S. Patent and Trademark Office
  • U.S. Copyright Office
  • U.S. International Trade Commission
  • World Intellectual Property Organization
  • POLICY & REGULATION
  • Patent reform legislation and related bills in Congress
  • Efforts to streamline international intellectual property law
  • ENFORCEMENT
  • Piracy and counterfeiting actions
  • International trade disputes involving IP issues
  • PROFILES
  • Personnel moves
  • Profiles of IP practices

Readership

  • Intellectual property lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the life sciences, technology, and other IP-focused industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals